SMLR - Wutah dodolan YoY sajrone 12 wulan kepungkur Semler

Partnerships with clinics and insurers for early vascular diagnostics provide Semler Scientific, Inc. (SMLR) with a competitive market advantage. Relative sales growth over the 12-month period compared to last year confirms this success, and the parameter has stabilized at -38.00. Revenues are based on the sale of QuantaFlo systems, while a stable cash flow is coupled with reserve volatility due to investments in crypto assets.
Ringkesan rincian data analitis Semler Scientific (SMLR)

For Semler Scientific, Inc. (SMLR), demand for non-invasive vascular diagnostics drives the pace of market expansion, as reflected in the trailing twelve months (TTM) year-over-year sales dynamics. This indicator compares current rolling revenue with the same period last year, revealing actual business acceleration and a shift in its fundamental phase, allowing investors to objectively assess the scalability of the company's US production capacities.